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Stimulation of beta2-microglobulin synthesis in lymphocytes after ex-
posure to Cuprophan dialyzer membranes. We tested beta2-microglob-
ulin (i32m) synthesis by peripheral blood lymphocytes of non-uremic
donors after contact with dialyzer membranes. Under serum-free
conditions, lymphocytes were incubated with different dialyzer mem-
branes for four hours. After subsequent culture in the absence of
membranes to yield an overall culture time of 24 hours, RNA was
extracted. Messenger RNA for 2m was quantitated by Northern
blotting with specific probes. Increased f3,m mRNA was seen after a
minimum of one hour contact time with Cuprophan both in the presence
and absence of cyclohexitnide. While no consistent stimulation was
seen with polyacrylonitrile or polycarbonate-polyether membranes,
respectively, the stimulation of 132m mRNA with Cuprophan was of the
same order of magnitude as that obtained with interferon gamma.
Stimulation of 32m mRNA by Cuprophan was stereospecifically dimin-
ished by 5 mM L-fucose. Apart from stimulated transcription of 132m we
could also show increased surface expression of MHC class I mole-
cules, using FACS technique. The results further prove complement-
independent blood cell activation by Cuprophan membranes. It is
uncertain whether the results are relevant for f32m amyloidosis.
Interaction of blood cells with dialysis membranes causes cell
activation as indicated by a rise in intracellular Ca2, increased
turnover of cell membrane phospholipids, stimulation of pros-
taglandin synthesis, release of interleukin I and other parame-
ters [1, 2]. Activation occurs via complement dependent and
independent pathways [1, 3, 4].
Activated cells express large amounts of MHC class I anti-
gens on their plasma membranes [5, 6]. Beta2-microglobulin
(132m) constitutes the light chain of MHC class I molecules [7].
We addressed the question whether assessing translation of
the 132m gene might provide a novel approach to investigate
blood cell activation by contact with dialyzer membranes. The
choice of /32m seems particularly interesting since /3,m is the
precursor peptide of the unique form of amyloid which occurs
in patients on long-term hemodialysis [8—12]. To this end we
measured f32m specific mRNA and MHC class I or /32m expres-
sion, respectively, on the cell surface of lymphocytes of non-
uremic donors.
Methods
Isolation of peripheral blood lymphocytes
Mononuclear cells were isolated by density centrifugation of
buffy-coat cells from healthy donors on Ficoll-Hypaque (Se-
romed Co, Berlin, Germany). After washing, adherent cells
(that is, monocytes/macrophages) were removed by two con-
secutive steps of polystyrene adherence (90 mm each). About
60% of original cells were recovered and analyzed by cytoflu-
orometry as described below. About 1.5% stained positively for
LeuM3, 20% for Leul6, 78% for OKTI1 and 75% for OKT3.
Culture medium was RPMI 1640 (Biochrom Co, Berlin, Ger-
many), supplemented with 100 U/ml penicillin and 100 jig/mi
streptomycin (Gibco Co, Karisruhe, Germany). Unless stated
otherwise, cells were used at a concentration of 5 x 106/ml.
Preparation of dialyzer membranes
Cuprophan° flat sheet membranes were taken from com-
mercially available plate dialyzers (Lundia IC, Gambro Co.,
Lund, Sweden). Experimentally modified (DEAE-substitution)
cellulose membrane (Akzo-Enka Co, Wuppertal, Germany),
AN 69R (polyacrylonitrile) from Hospal Co., Mezieu, France,
and Gambrane' (polycarbonate-polyether) from Gambro Co.
were used. Circular pieces (140 cm2) of membranes were
sterilized in polystyrene petri dishes using ethylene oxide.
Sterilized devices were deaerated for 20 hours at 30°C in
vacuum. The membranes were washed twice in 75 ml sterile
phosphate-buffered saline (PBS, Seromed Co.), containing 1
jig/mI polymyxin B (Sebio Co, Walchsing, Germany), for 30
minutes and finally equilibrated in 75 ml culture medium for one
hour. Culture media were monitored regularly using LAL
technique; no endotoxin was found (detection threshold 0.06
nglml).
Exposure of lymphocytes to dialysis membranes
Rinsing medium was removed and 15 ml of lymphocyte
suspension (7.5 X iO cells) and 30 ml of culture medium were
added. In parallel sets lymphocytes were cultured under iden-
tical conditions in absence (medium control) and presence of
membranes, or—if cell yield permitted—also after addition of
y-interferon (800 U/mI, BASF Co., Ludwigshafen, Germany)
(positive control). After various incubation periods, as detailed
under results, the cells were harvested (recovery was approxi-
mately 85%) and further cultured in 150 ml culture medium to
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allow transcription of /32m mRNA and expression of MHC class
I surface molecules, respectively. For competitive inhibition
studies, different carbohydrates, that is, L-fucose, D-fucose
and L-mannose purchased from Serva Co (Heidelberg, Germa-
ny), were added to the culture medium to a final concentration
of 5 mM.
Isolation of RNA and Northern blotting
1 2 3 1 - Medium control
2 - Cuprophan 12 hr
3 - Interferon gamma 12 hr
Total cellular RNA was extracted from lymphocytes by the
acid-guanidinium-phenol-chioroform method. Briefly, cells
were collected by centrifugation and lysed by addition of 500 sl
guanidinthiocyanate (GITC 4M) containing 0.5% N-laurolylsar-
cosine, 25 m citric acid and 0.1 M /3-mercaptoethanol. All
subsequent steps were carried out according to the method
described by Chomczinsky and Sacchi [13]. The OD2,280 was
measured and the RNA concentration was adjusted to 2 gIpi.
To assess the importance of cells remaining adherent to the
membrane, we compared series with addition of GITC solution
directly to the membrane incubation system. No difference in
/32m mRNA was noted (data not given).
RNAs were electrophoresed on a 1% agarose gel in MOPS-
buffer (0.02 M morpholinopropane sulfonic acid, 0.005 M so-
dium acetate, 0.001 M EDTA) containing 2.2 M formaldehyde,
transferred to nylon membrane (GENE-SCREEN, NEN Co,
Dreieich, Germany) by capillary blotting in lOx SSC (NaCI 1.5
M, sodium citrate 0.15 M, pH 7.0), and cross linked by UV
illumination at 254 nm for two minutes.
For cytoplasmic dot blot preparation 1 x l0 cells were
pelleted and lysed by addition of 0.5% NP 40 (Sigma Co.
Munchen, Germany) in 50 pi TE buffer (10 mM Tris, 0.1 mM
EDTA, pH 7.6). All subsequent steps were performed as
described by White and Bankroft [14]. For hybridization,
aliquots of 20 pi (corresponding to 2 x 106 cells) were applied to
Gene Screen membranes (NEN Co) with the aid of a minifold
apparatus (Bio-Rad Co, MUnchen, Germany) and UV cross
linked at 254 nm for two minutes. Stepwise 1:3 dilutions were
done in 15 x SSC.
Hybridization of Northern blots and dot blots was performed
according to Thomas [15]. f32m specific cDNA was a gift from
Dr. S. Koch (DKFZ Heidelberg, FRG) [16]. A 760 bp Hind III
insert was recloned in a pBS-vector. Sal I linearized vector was
used for labeling with a T7 transcription kit (Boehringer Co,
Mannheim, Germany) [17]. The /3-actin specific cDNA was
from Dr. B. Heckl-Ostrreicher (Institut für Immunologie, Uni-
versitflt Heidelberg, Germany). A 1.2 kb EcoRI fragment cut
from puc 19 was labeled using a random priming kit (Boehringer
Co.), strictly following procedures given by the manufacturer.
Prehybridization (3 hr) and hybridization (14 hr) were per-
formed using 50% formamide, 5 x SSC, 50 mri sodium phos-
phate ph 6.5, 4 x Denhardt's solution (Sigma Co.), 0.5 mg/mI
yeast-RNA (Boehringer Co.), and 1% SDS at 42°C. After
hybridization, the membranes were washed three times for 30
minutes in 0.2 x SSC/1% SDS at 42°C. Autoradiography and
relative quantitation by densitometry were performed accord-
ing to standard procedures.
Surface marker analysis
The following monoclonal or polyclonal antibodies were used
in direct or indirect immunofluorescence staining procedures:
the Leu series from Becton Dickinson Co. (Mountain View,
13-actin mRNA
Fig. 1. Induction of /32m-spece/ic mRNA after exposure of lymphocytes
to Cuprophan membranes. Ten jsg of total RNA per lane were applied.
RNA was obtained from unstimulated (1), Cuprophan-stimulated (2),
and y.interferon stimulated (3) lymphocytes. /32m-specific and f3-actin
specific mRNA were detected by Northern blotting.
California, USA), OKTI I from Ortho Pharmaceuticals Co
(Raritan, New Jersey, USA), mab w6/32- (anti-MHC class I
framework) from American Type Culture Collection (Bethesda,
Maryland, USA). FITC-conjugated F(ab')2 goat anti-mouse IgG
and 1gM antibodies were used as a second-step reagent for
staining unconjugated mouse monoclonal antibodies. /32m was
detected by using polyclonal antibodies from rabbit (Dako Co)
which were detected in a second step by FITC-conjugated
donkey anti-rabbit IgG (Dianova Co, Hamburg, Germany).
For staining, cells were resuspended from culture flasks and
washed twice in PBS containing 1% BSA (Serva Co.) and 0.1%
NaN3 (Sigma Co.). Staining procedures were performed in
V-shaped 96-well microtiter plates (Greiner Co., Nurtingen,
Germany). For each sample staining was performed with at
least l0 cells per well. Pellets were resuspended in saturating
amounts of antibodies and incubated for 30 minutes at 4°C. For
indirect staining, cells were incubated for additional 30 minutes
at 4°C with the second step reagent. After extensive washing,
the cells were resuspended in PBS/1% paraformaldehyde (PFA,
Sigma Co.). Fluorescence intensity of specifically bound anti-
bodies was analyzed by flow cytometry using FACScan equip-
ment (Becton Dickinson Co.). Cells were identified on the basis
of light scattering properties (forward and side scatter).
Results
Demonstration of increased f32m mRNA in lymphocytes after
contact with Cuprophan
In a first series of experiments, isolated lymphocytes were
exposed to Cuprophan under serum-free conditions for 12
hours. RNA was extracted after additional incubation for 12
hours in culture flasks. After electrophoresis and blotting,
/32m-specific mRNA was identified by hybridization with a
32P-labeled cDNA-probe highly specific for f32m. Subsequently
filters were rehybridized with a /3-actin specific cDNA. As
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fold higher after incubation of lymphocytes with gamma-inter-
feron and between 2.2-fold and five-fold higher after incubation
with Cuprophan (Figs. I and 2). For comparison other dialyzer
materials, polyacrylonitrile (AN69) or polycarbonate—poly-
ether (Gambrane), were tested in regard to their ability to
induce /32m synthesis. In a limited number of experiments no
stimulation was seen with polycarbonate-polyether; a variable
response to polyacrylonitrile can not be excluded. To test for
responsiveness of lymphocytes to LPS, contamination with
which is always a possibility during in vitro studies, the cells
were not incubated with membranes, but with LPS 5 g/ml for
the same period and further cultured up to 24 hours. Assess-
ment of 32m-specific mRNA did not show an increase after LPS
incubation (data not shown).
Increase of f32m mRNA time course
For kinetic studies, lymphocytes were incubated with Cu-
prophan for different time periods (I hr, 4 hr and 12 hrs) before
RNA was extracted for cytoplasmic dot blot hybridization and
autoradiography (Fig. 3). Exposure to Cuprophan for one hour
caused a 1.5-fold increase of J32m//3-actin mRNA ratio com-
pared to untreated cells and a two-fold increase after four
hours. As longer incubation times had no further effect, all
subsequent experiments were carried out with a contact time of
four hours.
Role of carbohydrate receptor(s) in cell activation
We had previously reported [1] that L-fucose inhibits stimula-
tion of monocytes by Cuprophan, assessed by intracellular
calcium levels and mediator release. This finding suggested that
L-fucose interferes stereospecifically with a stimulating signal.
To study the effect of L-fucose on the induction of 132m
message by Cuprophan in peripheral blood lymphocytes, we
exposed lymphocytes to Cuprophan for four hours in the
presence of 5 mi L-fucose. The /32m!/3-actin mRNA ratio after
Cuprophan contact was less after coincubation with L-fucose;
no effect was seen with the stereoisomer D-fucose and with
Fig. 3. Time course of mRNA induction by Cuprophan. Lymphocytes
were incubated with Cuprophan for the indicated time periods. After 24
hours j32m and f3-actin specific mRNAs were assessed by dot blot
hybridization. /32m//3-actin ratios were calculated from optical densities
(OD) of autoradiographs. The values of medium control were taken
as internal reference value of one.
L-mannose (Fig. 4). In a control experiment L-fucose did not
interfere with y-interferon induced stimulation of /32m mRNA.
Role of protein synthesis in the increase of 132m mRNA
The next experiment was designed to examine whether the
change in $2m mRNA was dependent on de novo synthesis of
mediators, such as y-interferon, interleukins, or other proteins.
To this end, we blocked protein synthesis at different times
after exposure to Cuprophan by cycloheximide at a concentra-
tion that inhibited the incorporation of 35S-cystein into mem-
brane proteins. After culturing for 24 hours, cells were harvested
and assessed for /32m- and 13-actin mRNA by cytoplasmic dot-blot
hybridization. Coincubation with 20 sM cycloheximide for
various periods of time (legend in Fig. 5) did not diminish the
increment in 132m/13-actin mRNA ratio triggered by Cuprophan.
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Fig. 2. Comparison of f32m mRNA induction by
different membranes, Symbols are: (El) cellulose; (D)
polyacrylonitrile; (0) polycarbonate; (0) interferon;
(0) control. In 4 experiments lymphocytes were
incubated for four hours with the respective membrane
or y-interferon. After 24 hours f32m and 13-actin specific
mRNAs were assessed by dot blot hybridization. /32m1/3-
actin ratios were calculated from optical densities
(OD) of autoradiographs. The values of medium
controls were taken as internal reference value of one.
te..
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Fig. 4. Stereospecific inhibition of Cuprophan-triggeredi-actin mRNA increase in j32m mRNA levels by L-fucose. Lymphocytes
were exposed to Cuprophan membranes for four hours in
the presence or absence of the indicated carbohydrates at a
final concentration of 5 m. 132m specific mRNA was
identified by dot-blot hybridization (undiluted samples,
diluted 1/3, 1/9, 1/27). Values represent optical densities of
autoradiographs from undiluted dots (600 nm) of m
hybridization. For control rehybridization with /3-actin
specific eDNA is shown. The autoradiograph is from













Exposure time to cycloheximide
Fig. 5. Effect of cycloheximide on the increment in f32m mRNA after
contact with Cuprophan. Lymphocytes were incubated with Cu-
prophan for four hours and after an overall culture time of 24 hour cells
were harvested for RNA extraction. Cycloheximide was present during
the whole culture time of 24 hours (24 hr), or was added 30 mm and 60
mm, respectively, after start of Cuprophan incubation (24 hr-30 mm and
24 hr-60 mi. 132m and /3-actin specific mRNAs were assessed by dot
blot hybridization. p2m//3-actin ratios were calculated from optical
densities (OD) of autoradiographs. The values of medium control
were taken as internal reference value of one.
Evaluation of chemically-modified cellulosic membranes
Since covalently-modified cellulosic membranes are known
to have altered activation properties with respect to comple-
ment and other mediator systems, we examined /32m mRNA of
lymphocytes after exposure to cationically (DEAE) modified
cellulose. No significant difference was noticed between DEAE
cellulose and unmodified cellulose (Cuprophan) (Fig. 6).
Beta2-micro globulin and MHC class I expression on cell
surfaces
Cytofluorometric analysis was performed to examine
whether the increment in f32m mRNA triggered by Cuprophan
leads to enhanced surface expression of 132m and HLA class I
framework antigens (Fig. 7). Cells were exposed to Cuprophan
for four hours, then collected and cultured for additional 36
hours to allow an increase of surface molecule expression. They
were then harvested and stained for cytofluorometric analysis
as described.
After exposure to Cuprophan enhanced f32m expression was
seen in a subpopulation of lymphocytes that initially had low
f32m expression. The proportion of f32m-expressing cells in-
Fig. 6. Comparison of cationically modified (DEAE) and unmodtfied
cellulose membrane. Lymphocytes were incubated either with modified
or unmodified cellulose membranes for four hours. Symbols are: (D)
control; () Cuprophan; (0) DEAE cellulose. After an overall culture
time of 24 hours, f32m- and 13-actin-specific mRNAs were assessed by
dot blot hybridization. /32m/f3-actin ratios were calculated from optical
densities (OD) of autoradiographs. The values of medium control
were taken as internal reference value of one. The Figure shows two
independent experiments.
creased from 58% to 75% in a first series (3 replicate measure-
ments) and from 54% to 71% in a second series (Fig. 7A).
When lymphocytes were stained with an anti-HLA-class I
framework antibody (w6/32), exposure to Cuprophan led to
higher expression of class I molecules, indicated by increased
fluorescence intensity (Fig. 7B).
Discussion
Incubation of a lymphocyte preparation (mainly consisting in
T cells) with Cuprophan dialyzer membranes leads to an
increase in f32m-specific mRNA. Paralleling observations on the
release of mediators from monocytes after contact with Cu-
prophan [1], stimulation of lymphocytes occurred in the ab-
sence of complement and complement-derived split products.
We propose that direct contact of cells with specific foreign
surfaces is sufficient to provide a signal for cell activation.
This assay system may constitute one approach to character-
ize membrane surface properties which are relevant for direct
(blood) cell activation. It is known that in vivo the dialyzer
membrane is rapidly coated by serum proteins. Whether such
coating interferes with the activation signal requires further
study.
Comparison of membranes showed that induction of f32m
Culture condition Extinction t2m mRNA
(OD 600)
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Fig. 7.A. Gytofluorometric analysis of 132m-expression on unstimu-
lated (---) andcuprophan-stimulated (...) lymphocytes. The cell number
(ordinate, linear scale) was plotted against fluorescence intensity (ab-
scissa, logarithmic scale). Gate was set for lymphocytes. Results were
confirmed by three replicate measurements of two experiments. B.
Cytofluorometric analysis of HLA class I antigen expressed on unstim-
ulated (...) and cuprophan stimulated (---) lymphocytes. The cell
number (ordinate, linear scale) was plotted against fluorescence inten-
sity (abscissa, logarithmic scale). Gate was set for lymphocytes. Results
were confirmed by three replicate measurements of two experiments.
synthesis is a characteristic property of unmodified and modi-
fied cellulosic membranes. So far, the structure on the Cu-
prophan responsible for the stimulation is not known. Coincu-
bation with monomeric L-fucose, but not its stereoisomer
D-fucose or D-mannose, inhibited the generation of 132m-
specific mRNA. This observation favors the hypothesis that
L-fucose interacts specifically with a receptor molecule on the
lymphocyte surface, thus preventing receptor binding by a
complementary structure on the dialyzer membrane. Various
carbohydrate receptors have been described on monocytes [18]
and it is quite possible that an analogous structure on lympho-
cytes is triggered by the hypothetical complementary structure
on the Cuprophan membrane.
Chemically-modified cellulosic membranes triggered the cells
to a similar degree. It must be considered, however, that
modification of end groups does not necessarily result in a
modification of carbohydrates presented on the surface of the
dialyzer membrane.
The signal transduction pathway is still under investigation.
Coincubation with cycloheximide did not prevent the rise in
132m//3-actin mRNA ratio. This argues against involvement of de
novo synthesis of protein or polypeptide mediators. The 132m1
f3-actin mRNA ratio was even higher in the presence of cyclo-
heximide, possibly due to superinduction [19, 20].
The magnitude of the signal was comparable with that seen
after interferon-gamma, a known stimulant of 13,m gene tran-
scription. This does not necessarily indicate that Cuprophan is
an equally potent stimulus, as the time of stimulation might not
have yielded the maximal response to interferon-gamma.
We further tested whether the increase of j32m specific
mRNA also resulted in increased cell surface expression of
either f37m or MHC class I antigen. Enhanced expression was
found after relatively brief contact of lymphocytes with the
Cuprophan. Although increased surface expression could in
principle be explained by redistribution of /32m and MHC
glycoprotein molecules, it is more likely that this reflects de
novo synthesis.
One intriguing problem remains unsolved, that is, whether
increased translation of /32m in blood cells would lead to release
of f32m molecules into the extracellular fluid phase. Recently,
Hakim, Zaoui and Stone [21] reported that measurable amounts
of /3,m were detected in the supernatant of peripheral blood
cells after cultivation in contact with cuprophan membranes.
Considering the high rate of synthesis, 2.8 to 4.6 mg/kg x day as
measured by Karlsson, Wibell and Evrin [221, it remains to be
seen whether release from circulating blood cells could make a
quantitatively significant contribution to plasma levels. It is also
still unsettled whether or not the net generation of f32m is
increased in dialysis patients [23, 24].
With regard to the development of the 2m amyloid, one
further possibility deserves consideration, that is, the release of
proteolytically-modified f32m molecules by activated blood
cells. Recently Linke et al documented that 2m derived
amyloid fibrils of dialysis patients consist, at least in part, of
f32m modified by lysin specific proteolysis [25]. The activity of
various protease increases upon activation of blood cells [261.
Furthermore, /32m derived fragments with lower molecular
weight and less positive charge are found in the circulation of
dialysis patients [12, Linke personal communication]. It is
conceivable that such f32m fragments are released into the
circulation by cells remote from amyloid deposits.
Finally, we wish to point to the considerable potential of
further studies on the transcriptional and translational control
of f32m as a model gene (the product of which can easily be
monitored and is of potential biological importance). This
system will permit the elucidation of the activation signal and
intracellular transduction pathways involved in activation by
B
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dialysis membranes. Furthermore, this system might be helpful
in the more rational design of new dialyzer membranes.
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